Increased nitric oxide synthase isoforms, endothelin 1 and apoptosis varied in lungs from patients with (SSc) and had impact on pulmonary function tests

A. C. Aguiar Junior, S. Fernezlian, V. L. Capelozzi, E. R. Parra (Brazil)

Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Session: Biomarkers in diffuse parenchymal lung disease
Session type: E-Communication Session
Number: 5670
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. C. Aguiar Junior, S. Fernezlian, V. L. Capelozzi, E. R. Parra (Brazil). Increased nitric oxide synthase isoforms, endothelin 1 and apoptosis varied in lungs from patients with (SSc) and had impact on pulmonary function tests. Eur Respir J 2010; 36: Suppl. 54, 5670

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Increased expression of inducible nitric oxide synthase (iNOS) in peripheral lung of severe COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 95s
Year: 2002

Expression of endothelial nitric oxide synthase (eNOS) and endothelin-1 (ET-1) in pulmonary arteries of patients with severe COPD
Source: Annual Congress 2003 - Pathophysiology of the pulmonary circulation
Year: 2003


Increased eNO and pulmonary iNOS expression in eNOS null mice
Source: Eur Respir J 2003; 21: 770-773
Year: 2003



The role of nitric oxide (NO) on sepsis-induced pulmonary apoptosis
Source: Eur Respir J 2001; 18: Suppl. 33, 358s
Year: 2001

Increased alveolar concentrations of exhaled nitric oxide (NO) are associated with lung affection in systemic sclerosis (SSc)
Source: Eur Respir J 2005; 26: Suppl. 49, 543s
Year: 2005

LSC 2013 abstract - The role of inducible nitric oxide synthase (iNOS) for the remodeling of alveolar septa in surfactant protein D deficient mice
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013


Inhaled nitric oxide decreases pulmonary endothelial nitric oxide synthase expression and activity in normal newborn rat lungs
Source: ERJ Open Res 2016
Year: 2016


Augmented lower respiratory tract nitric oxide production in eNOS deficient mice is related to upregulation of pulmonary iNOS expression
Source: Eur Respir J 2001; 18: Suppl. 33, 253s
Year: 2001

Expression of inducible nitiric oxide synthase (iNOS) in airway epithelial cells is reduced in young children with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 231s
Year: 2003

Reduce expression of endothelial nitric oxide synthase lead to more severe pulmonary complex vascular lesions associated with HIV
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018

Expression of nitric oxide synthases (NOS) in quadriceps of COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 423s
Year: 2001

Gender specific association of the endothelial nitric oxide synthase (NOS3) gene polymorphisms with allergic diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 140s
Year: 2005

Nitric oxide synthase gene expression and its relation with the lung vascular injury in pneumonia of immunosupressed rats
Source: Eur Respir J 2005; 26: Suppl. 49, 731s
Year: 2005

Inhaled no decreased endothelial nitric oxide synthase expression in normal newborn rat lungs
Source: Annual Congress 2009 - Respiratory disorders of the newborn
Year: 2009


Upregulation of the inducible form of the nitric oxide synthase and nitrotyrosine formation in skeletal muscle of COPD patients with cachexia
Source: Eur Respir J 2002; 20: Suppl. 38, 211s
Year: 2002

Gene polymorphisms of endothelial nitric oxide synthase in pulmonary arterial hypertension
Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Year: 2005


The inducible nitric oxide synthase (NOS2) gene promoter polymorphisms and bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 106s
Year: 2005

Combined effects of type 2 inflammation and lung function on exhaled nitric oxide ability to reflect asthma control
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019


Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen
Source: Eur Respir J 2003; 21: 394-400
Year: 2003



Changes in nitric oxide production in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 190s
Year: 2006